Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bone Loss
Alfacalcidol exerts higher bone-protective properties with fewer side effects
November 17th, 2005
Scientists reported that alfacalcidol exerts higher bone-protective properties with fewer side effects. According to a study from Belgium, "In postmenopausal osteoporosis, the administration of alfacalcidol to women resulted in an increase in trabecular bone mineral density (BMD), prevention of cortical bone loss, and a significant reduction in the incidence of further vertebral fractures. There is now robust evidence that alfacalcidol may be particularly active in conditions characterized by an increased rate of bone loss. Alfacalcidol 1 mcg/day fully prevented vertebral bone loss over 3 years in women after the first year of menopause." "In a large...
Source: Women's Health Weekly (2005-11-17)
|
